← Back to catalogue
Neteera 130H-Plus
EUDAMEDFDA 510(k)Class IIa (EU MDR)
Ref 210-00-103-00510(k) K231733
Identity
- Trade Name
- Neteera 130H-Plus EUDAMED
- Device Name
- Neteera 130H-Plus EUDAMED
- Model / Reference
- 210-00-103-00 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 07290117120002 EUDAMED
- Basic UDI-DI
- 729011712130H-PlusXH EUDAMED
- 510(k) Number
- K231733 FDA 510(k)
- FDA Product Code
- DRT FDA 510(k)
- EMDN Code
- Z12030201 CENTRAL INFORMATION COMPUTING SYSTEMS EUDAMED
Classification
- Device Class
- Class IIa EUDAMEDClass II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 870.2300 FDA 510(k)
- Regulation Number
- 870.2300 FDA 510(k)
- Market of Registration
- Germany EUDAMED
- Advisory Committee
- Cardiovascular FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Neteera 130H-Plus by Neteera Technologies Ltd — Class IIa — FDA_510K, MDR — listed in EUDAMED, FDA 510(k) — regulatory data on deviCERTS
Authorization Coverage (2 countries)
Regulatory Authorizations
United States Active
FDA_510K
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K231733 | Class IIa | Active |
| EUDAMED | European Union | CE/MDR | 729011712130H-PlusXH | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Neteera Technologies Ltd.
- EUDAMED SRN
- IL-MF-000043595
- Authorised Representative
- MedNet EC-REP GmbH DE-AR-000000002
Sources (2)
- EUDAMED 97d3288e-96f2-4174-ba97-80e4a8c56679 61 fields · synced Jul 9, 2026
- FDA 510(k) K231733 24 fields · synced May 18, 2026